SPONSOR
Daewoong Pharmaceutical Co. LTD.
Total Trials
3
Recruiting
3
Phases
Phase 1
Daewoong Pharmaceutical Co. LTD. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Healthy Subjects, Obesity & Overweight, Type 2 Diabetes, Autoimmune Diseases.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Daewoong Pharmaceutical Co. LTD.
How many clinical trials has Daewoong Pharmaceutical Co. LTD. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Daewoong Pharmaceutical Co. LTD., of which 3 are actively recruiting participants. These trials cover conditions including Healthy Subjects, Obesity & Overweight, Type 2 Diabetes. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Daewoong Pharmaceutical Co. LTD. research focus on?
Daewoong Pharmaceutical Co. LTD. clinical trials span Healthy Subjects, Obesity & Overweight, Type 2 Diabetes, Autoimmune Diseases. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Daewoong Pharmaceutical Co. LTD. clinical trial?
To participate in a Daewoong Pharmaceutical Co. LTD. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Daewoong Pharmaceutical Co. LTD. trials with current recruitment status updated daily.
Clinical Trials by Daewoong Pharmaceutical Co. LTD.
NCT07144176 Phase 1
Recruiting
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
Healthy Subjects
NCT07539415 Phase 1
Recruiting
A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers
Obesity & Overweight
NCT06736587 Phase 1
Recruiting
Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers
Autoimmune Diseases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology